Catalyst Pharmaceutical
CPRX
CPRX
140 hedge funds and large institutions have $299M invested in Catalyst Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 131 → 140 (+9)
1.18% less ownership
Funds ownership: 63.76% → 62.58% (-1.2%)
15% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 47
Holders
140
Holding in Top 10
2
Calls
$1.01M
Puts
$134K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$4.35M | |
| 3 | +$3.7M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.38M |
| 5 |
RA
Royce & Associates
New York
|
+$3.08M |
Top Sellers
| 1 | -$5.66M | |
| 2 | -$3.83M | |
| 3 | -$3.59M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.37M |